Search

Home > News & Events > Current News

Current News

Current SATVI news

25 September 2018 Latest Research: Candidate tuberculosis (TB) vaccine can prevent active pulmonary TB in HIV-negative adults in phase II study
Tuesday, September 25, 2018 - 17:45

The New England Journal of Medicine has just published the primary results of an ongoing phase IIb clinical trial testing the candidate tuberculosis vaccine M72/AS01E which demonstrates that the M72/AS01E vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults who were already infected with latent TB at the time of vaccination.

7 September 2018 Latest Research: PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
Friday, September 7, 2018 - 16:00

SATVI Researcher Marwou de Kock has co-authored a research article titled: "PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis" appearing in the Frontiers in Immunology journal.

Latest Research: Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
Wednesday, September 5, 2018 - 11:45

SATVI Associate Professor Tom Scriba has co-authored a research paper titled "Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination" appearing in the Scientific Reports journal.

Coming Event: Kick TB Poster and Writing Exhibit
Monday, August 27, 2018 - 10:30

SATVI and the Western Department of Education are pleased to announce the hosting of the Kick TB Poster Art and Writing Exhibit on Monday 3 September 2018.

22 August 2018 Research Published: Infectious Diseases: Natural killers associated with latent Tuberculosis
Wednesday, August 22, 2018 - 22:00

SATVI authors Associate Professor Tom Scriba, Drs. Elisa Nemes, Adam Penn-Nicholson, Virginie Rozot and Fatoumatta Darboe have co-authored an article titled: "A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes" appearing in the Nature Journal.

20 August 2018 Research Published: Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes
Tuesday, August 21, 2018 - 11:15

Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.

17 August 2018 Research: Prospects for a vaccine to prevent HIV related Tuberculosis
Monday, August 20, 2018 - 15:45

SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.

Celebrating the legacy of Nelson Mandela
Thursday, July 19, 2018 - 12:45

For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.

Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.
Thursday, July 12, 2018 - 08:15

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.

Vaccine Honours students
Wednesday, June 27, 2018 - 21:00

On Friday 22 June 2018 the Worcester SATVI field site hosted UCT Honours Vaccinology students.

Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts
Tuesday, May 29, 2018 - 14:15

SATVI's Associate Professor Tom Scriba has co-authored a research paper titled "Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts" appearing in the Frontiers in Immunology.

11 April 2018 SATVI 2017 Annual Report Now available
Wednesday, April 11, 2018 - 13:00

The 2017 SATVI Annual Report is now available.

Pages